These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15615109)

  • 1. ATP P2 receptors and regulation of bone effector cells.
    Gallagher JA
    J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):125-7. PubMed ID: 15615109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of P2 receptors in bone.
    Gallagher JA; Buckley KA
    J Musculoskelet Neuronal Interact; 2002 Sep; 2(5):432-9. PubMed ID: 15758411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2 receptors in bone--modulation of osteoclast formation and activity via P2X7 activation.
    Gartland A; Buckley KA; Hipskind RA; Bowler WB; Gallagher JA
    Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):237-42. PubMed ID: 14696970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the pore-forming P2X7 receptor inhibits formation of multinucleated human osteoclasts in vitro.
    Gartland A; Buckley KA; Bowler WB; Gallagher JA
    Calcif Tissue Int; 2003 Oct; 73(4):361-9. PubMed ID: 12874700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling.
    Hoebertz A; Mahendran S; Burnstock G; Arnett TR
    J Cell Biochem; 2002; 86(3):413-9. PubMed ID: 12210747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [P2 purinergic receptors: regulation of bone metabolism and therapeutic potential?].
    Solgaard M; Jørgensen NR
    Ugeskr Laeger; 2005 Aug; 167(34):3152-6. PubMed ID: 16117911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P2 receptor signaling in neurons and glial cells of the central nervous system.
    Köles L; Leichsenring A; Rubini P; Illes P
    Adv Pharmacol; 2011; 61():441-93. PubMed ID: 21586367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of P2 receptors in bone and cultured bone cells.
    Hoebertz A; Townsend-Nicholson A; Glass R; Burnstock G; Arnett TR
    Bone; 2000 Oct; 27(4):503-10. PubMed ID: 11033445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
    Tomé AR; Castro E; Santos RM; Rosário LM
    BMC Neurosci; 2007 Jun; 8():39. PubMed ID: 17570839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation: involvement of metabotropic P2 receptors.
    Agresti C; Meomartini ME; Amadio S; Ambrosini E; Volonté C; Aloisi F; Visentin S
    Brain Res Brain Res Rev; 2005 Apr; 48(2):157-65. PubMed ID: 15850654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of ERK 1/2 and p38 MAPK signaling pathways by ATP in osteoblasts: involvement of mechanical stress-activated calcium influx, PKC and Src activation.
    Katz S; Boland R; Santillán G
    Int J Biochem Cell Biol; 2006; 38(12):2082-91. PubMed ID: 16893669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Lee DH; Park KS; Kong ID; Kim JW; Han BG
    BMC Immunol; 2006 Sep; 7():22. PubMed ID: 16970829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of P2 receptors in the growth and survival of neurons in the CNS.
    Franke H; Illes P
    Pharmacol Ther; 2006 Mar; 109(3):297-324. PubMed ID: 16102837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
    Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
    BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotonic stress activates BK channels in clonal kidney cells via purinergic receptors, presumably of the P2Y subtype.
    Hafting T; Haug TM; Ellefsen S; Sand O
    Acta Physiol (Oxf); 2006 Sep; 188(1):21-31. PubMed ID: 16911250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of purinergic receptor polymorphisms in human bone.
    Wesselius A; Bours MJ; Agrawal A; Gartland A; Dagnelie PC; Schwarz P; Jorgensen NR
    Front Biosci (Landmark Ed); 2011 Jun; 16(7):2572-85. PubMed ID: 21622196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation.
    Coutinho-Silva R; Stahl L; Cheung KK; de Campos NE; de Oliveira Souza C; Ojcius DM; Burnstock G
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1024-35. PubMed ID: 15662049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-range intercellular calcium signaling in bone.
    Jørgensen NR
    APMIS Suppl; 2005; (118):5-36. PubMed ID: 16279161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.